NOD2 drives regenerative fetal-like reprogramming in the intestinal epithelium

D Derek K. L. Tsang (Department of Immunology, University of Toronto) C Charles Maisonneuve (Centre for Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital) A Arshad Ayyaz (Department of Biological Sciences, University of Calgary) E Elisabeth G. Foerster (Department of Immunology, University of Toronto) M Marry Nissan (Department of Laboratory Medicine and Pathobiology, University of Toronto) L Lauren Baerg (Institute of Biomedical Engineering, University of Toronto) D Daniel Trcka (Centre for Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital) B Bibaswan Ghoshal (Centre for Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital) B Boyan K. Tsankov (Department of Immunology, University of Toronto) G Giuliano Bayer (Department of Immunology, University of Toronto) M Madison Denney (Department of Laboratory Medicine and Pathobiology, University of Toronto) C Catherine J. Streutker (Department of Laboratory Medicine and Pathobiology, University of Toronto) J Jeffrey L. Wrana S Stephen E. Girardin (Department of Immunology, University of Toronto) D Dana J. Philpott (Department of Immunology, University of Toronto)

Abstract

Inflammatory injury to the intestine triggers a reprogramming of the intestinal epithelium to a fetal-like state that drives rapid restoration of the epithelial barrier. Although the intestinal microbiota is a key modulator of inflammation, its role in influencing epithelial fetal-like stem cell reprogramming and consequent restitution remains unclear. Using irradiation (IR) injury as a model for small intestinal epithelium injury and repair, we found that the intestinal microbiota accelerated epithelial restitution by amplifying a repair-associated inflammatory response that promoted the emergence of fetal-like intestinal epithelial cells (IECs), marked by Ly6a and Clu . NOD2 , the strongest genetic link to the development of Crohn’s disease, was found to be expressed in fetal-like IECs following injury. Employing an ileal organoid model, we demonstrated that NOD2 activation by its peptidoglycan ligand potentiated an inflammatory gene signature characterized by interferon signaling, concurrent with enterocyte recovery. NOD2 deficiency exacerbated epithelial apoptosis following IR injury, whereas epithelial-specific NOD2 signaling promoted fetal-like IEC emergence and increased epithelial proliferation. Collectively, these findings reveal a pivotal role for the microbiota and NOD2-mediated microbial sensing in regulating fetal-like IEC fate after injury, thus contributing to the protective function of this microbial sensor during intestinal inflammation.

Article Details

Volume / Issue Vol. 123, Issue 18
Published May 05, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (15)

D

Derek K. L. Tsang

Department of Immunology, University of Toronto

C

Charles Maisonneuve

Centre for Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital

A

Arshad Ayyaz

Department of Biological Sciences, University of Calgary

E

Elisabeth G. Foerster

Department of Immunology, University of Toronto

M

Marry Nissan

Department of Laboratory Medicine and Pathobiology, University of Toronto

L

Lauren Baerg

Institute of Biomedical Engineering, University of Toronto

D

Daniel Trcka

Centre for Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital

B

Bibaswan Ghoshal

Centre for Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital

B

Boyan K. Tsankov

Department of Immunology, University of Toronto

G

Giuliano Bayer

Department of Immunology, University of Toronto

M

Madison Denney

Department of Laboratory Medicine and Pathobiology, University of Toronto

C

Catherine J. Streutker

Department of Laboratory Medicine and Pathobiology, University of Toronto

J

Jeffrey L. Wrana

S

Stephen E. Girardin

Department of Immunology, University of Toronto

D

Dana J. Philpott

Department of Immunology, University of Toronto